학술논문
Assessment of Patient-Reported Outcomes at 48 Months of Treatment with Dupilumab for Severe Atopic Dermatitis: A Single-Center Real-Life Experience with 126 Patients
Document Type
Article
Author
Source
In: Pharmaceuticals . (Pharmaceuticals, January 2024, 17(1))
Subject
Language
English
ISSN
14248247